Skip to content
Neuropediatoolkit

Neuropediatoolkit

  • Toolkit
  • Guida clinica
  • Criterios de remisión
  • Scuola
  • Lab
  • File
  • Informazioni su
  • Login & Registro

PTEN.

Posted byAlberto Alcantud 11 settembre 20221 de November de 2026

Fondazione PHTS.

Posted byAlberto Alcantud11 settembre 20221 de November de 2026Posted inRischio oncologico

Post navigation

Previous Post Previous post:
Neurofibromatosi di tipo 1.
Next Post Next post:
Disturbi neurogenetici e rischio oncologico.
Neuropediatoolkit, Proudly powered by WordPress.
Italian
Spanish English German French Russian Chinese Japanese Portuguese Polish